Literature DB >> 6201177

Changes in the activities of microsomal enzymes involved in hepatic steroid metabolism in the rat after administration of androgenic, estrogenic, progestational, anabolic and catatoxic steroids.

E R Lax, P Baumann, H Schriefers.   

Abstract

Several steroids (5 beta-dihydrotestosterone, 19-nortestosterone, methyltrienolone, norethisterone, medroxyprogesterone acetate, cyproterone acetate, chlormadinone acetate and 16 alpha-cyanopregnenolone) were tested for their ability to influence the activities of three sexually differentiated hepatic microsomal enzymes (3 alpha- and 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase) in male and female gonadectomized and intact female rats. Of the steroids tested only 5 beta-dihydrotestosterone was completely ineffective. The other tested steroids elicited varying degrees of "masculinization" with a distinct gradation of effect according to the enzyme activity measured and animal model used. 5 alpha-Reductase was the most sensitive enzyme activity and 3 alpha-hydroxysteroid dehydrogenase the least. Male castrates responded better than female castrates, and these in turn better than intact females. The mechanism of action of three of the steroids (methyltrienolone, medroxyprogesterone acetate and norethisterone) was examined. Both flutamide and estradiol were able to block the action of methyltrienolone and medroxyprogesterone acetate, but not that of norethisterone. It is concluded that methyltrienolone and medroxyprogesterone acetate probably masculinize the enzyme activities by the same mechanisms as androgens, whereas the repression of 5 alpha-reductase activity elicited by norethisterone administration involves a different route.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201177     DOI: 10.1016/0006-2952(84)90175-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Gastric estrogen increases pituitary estrogen receptor α and prolactin mRNAs during the different pathological conditions of the liver.

Authors:  Hiroto Kobayashi; Saori Yoshida; Ying-Jie Sun; Nobuyuki Shirasawa; Akira Naito
Journal:  Endocrine       Date:  2012-07-28       Impact factor: 3.633

2.  Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial.

Authors:  Elahe A Mostaghel; Daniel W Lin; John K Amory; Jonathan L Wright; Brett T Marck; Peter S Nelson; Alvin M Matsumoto; William J Bremner; Stephanie T Page
Journal:  J Clin Endocrinol Metab       Date:  2012-06-01       Impact factor: 5.958

Review 3.  Progestogens with antiandrogenic properties.

Authors:  Daniel Raudrant; Thomas Rabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction.

Authors:  A P Stubbs; J L Engelman; J I Walker; P Faik; G M Murphy; M L Wilkinson
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

5.  Study of the effect of an anti-androgen (oxendolone) on experimentally induced canine prostatic hyperplasia. II. Endocrinological analysis.

Authors:  K Okada; K Oishi; O Yoshida; K Sudo; M Kawase; R Nakayama
Journal:  Urol Res       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.